Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Empirico
company
About
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $17M
- Industries
- Biotechnology,Medical
- Founded date
- Nov 7, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.The company's platform uses biological datasets, human genetics, and programmable biology to power target discovery and development, enabling scientists to systematically generate, interrogate, and prioritize high-confidence therapeutic hypotheses.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$17M
Empirico has raised a total of
$17M
in funding over 2 rounds. Their latest funding was raised on
Jan 9, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 9, 2020 | Series A | $17M | 1 |
Ionis Pharmaceuticals
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Empirico is funded by 1 investors.
Ionis Pharmaceuticals
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Ionis Pharmaceuticals
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
